UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interleukin‐34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment

International journal of cancer, 2015-07, Vol.137 (1), p.73-85

2015

Volltextzugriff (PDF)

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers

Journal of bone oncology, 2015-03, Vol.4 (1), p.1-12

2015

Volltextzugriff (PDF)

Mechanoresponsive stem cells to target cancer metastases through biophysical cues

Science translational medicine, 2017-07, Vol.9 (400)

2017

Volltextzugriff (PDF)

IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization

Cytokine (Philadelphia, Pa.), 2015-12, Vol.76 (2), p.170-181

2015

Volltextzugriff (PDF)

The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro

Arteriosclerosis, thrombosis, and vascular biology, 2010-02, Vol.30 (2), p.246-252

2010

Volltextzugriff (PDF)

A high throughput bispecific antibody discovery pipeline

Communications biology, 2023-04, Vol.6 (1), p.380-380, Article 380

2023

Volltextzugriff (PDF)

Functional TCR T cell screening using single-cell droplet microfluidics

Lab on a chip, 2018-12, Vol.18 (24), p.3733-3749

2018

Volltextzugriff (PDF)

Optimization of a syngeneic murine model of bone metastasis

Journal of bone oncology, 2020-08, Vol.23, p.100298-100298, Article 100298

2020

Volltextzugriff (PDF)

Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders

ACS nano, 2019-06, Vol.13 (6), p.6670-6688

2019

Volltextzugriff (PDF)

Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells

EBioMedicine, 2019-07, Vol.45, p.39-57

2019

Volltextzugriff (PDF)

Syndecan-1 regulates the biological activities of interleukin-34

Biochimica et biophysica acta, 2015-05, Vol.1853 (5), p.1010-1021

2015

Volltextzugriff (PDF)

Functional TCR T cell screening using single-cell droplet microfluidicsElectronic supplementary information (ESI) available. See DOI: 10.1039/c8lc00818c

2018-12

Volltextzugriff (PDF)

Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cellsResearch in context

EBioMedicine, 2019-07, Vol.45, p.39-57

2019

Volltextzugriff (PDF)

Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro

Cellular and molecular bioengineering, 2016-12, Vol.9 (4), p.509-529

2016

Volltextzugriff (PDF)

Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts

The American journal of pathology, 2017-01, Vol.187 (1), p.156-162

2017

Volltextzugriff (PDF)

Abstract 3744: Targeted therapy for breast cancer bone metastases using mRNA engineered mesenchymal stem cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3744-3744

2016

Volltextzugriff (PDF)

BMP-2 and TGF-β1 inhibit the expression of the pro-inflammatory cytokine IL-34 in rheumatoid arthritis synovial fibroblasts

The American journal of pathology, 2017-01, Vol.187 (1)

2017

Volltextzugriff (PDF)

IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization: IL-34/M-CSF: a new heteromeric cytokine

Cytokine (Philadelphia, Pa.), 2015-12, Vol.76 (2), p.170-181

2015

Volltextzugriff (PDF)

Preclinical mouse models of osteosarcoma

BoneKEy reports, 2015-05, Vol.4, p.670-670

2015

Volltextzugriff (PDF)

Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment: IL-34 promotes osteosarcoma progression

International journal of cancer, 2015-07, Vol.137 (1), p.73-85

2015

Volltextzugriff (PDF)

Interleukin-34 and macrophage-colony stimulating factor interact to form a heteromeric and functional cytokine

Bone Abstracts, 2014-05

2014

Volltextzugriff (PDF)

Chondroitin sulfate chains are co-receptors for interleukin- 34

Bone Abstracts, 2014-05

2014

Volltextzugriff (PDF)

Interleukin 34 promotes angiogenesis and increases blood cells adherence to endothelial cells

Bone Abstracts, 2014-05

2014

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(23)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interleukin‐34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers

Mechanoresponsive stem cells to target cancer metastases through biophysical cues

IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization

The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro

A high throughput bispecific antibody discovery pipeline

Functional TCR T cell screening using single-cell droplet microfluidics

Optimization of a syngeneic murine model of bone metastasis

Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders

Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells

Syndecan-1 regulates the biological activities of interleukin-34

Functional TCR T cell screening using single-cell droplet microfluidicsElectronic supplementary information (ESI) available. See DOI: 10.1039/c8lc00818c

Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cellsResearch in context

Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro

Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts

Abstract 3744: Targeted therapy for breast cancer bone metastases using mRNA engineered mesenchymal stem cells

BMP-2 and TGF-β1 inhibit the expression of the pro-inflammatory cytokine IL-34 in rheumatoid arthritis synovial fibroblasts

IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization: IL-34/M-CSF: a new heteromeric cytokine

Preclinical mouse models of osteosarcoma

Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment: IL-34 promotes osteosarcoma progression

Interleukin-34 and macrophage-colony stimulating factor interact to form a heteromeric and functional cytokine

Chondroitin sulfate chains are co-receptors for interleukin- 34

Interleukin 34 promotes angiogenesis and increases blood cells adherence to endothelial cells

Suchergebnisse filtern